Wednesday, October 22, 2014 3:11:56 PM
In this PR of Aug 12, they made it sound like testing would be complete by Sept 12.
http://finance.yahoo.com/news/itonis-pharmaceuticals-announces-first-emesyl-123000978.html
The actual process may be iterative, if someone with experience in this may comment, but perhaps ITNS proposes an initial expiration date on the box, then a period of trial in the market place happens to confirm it.
An expiration date of one year would take a long time to confirm if it is adequate, if the product starts breaking down before that, it would not be good.
It is my opinion that ITNS has been blindsided by this whole topic.
Are we rich yet?
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM